Adams Asset Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.8M | Hold |
62,912
| – | – | 1.8% | 19 |
|
|
2026
Q1 | $13.7M | Hold |
62,912
| – | – | 1.53% | 22 |
|
|
2025
Q4 | $14.4M | Sell |
62,912
-517
| -0.8% | -$118K | 1.89% | 13 |
|
|
2025
Q3 | $14.7M | Hold |
63,429
| – | – | 1.89% | 11 |
|
|
2025
Q2 | $11.8M | Sell |
63,429
-7,126
| -10% | -$1.32M | 1.66% | 16 |
|
|
2025
Q1 | $14.8M | Hold |
70,555
| – | – | 2.03% | 10 |
|
|
2024
Q4 | $12.5M | Sell |
70,555
-1,000
| -1% | -$184K | 1.61% | 14 |
|
|
2024
Q3 | $14.1M | Sell |
71,555
-254
| -0.4% | -$47.4K | 1.87% | 9 |
|
|
2024
Q2 | $12.3M | Hold |
71,809
| – | – | 1.61% | 14 |
|
|
2024
Q1 | $13.1M | Sell |
71,809
-362
| -0.5% | -$62.4K | 1.69% | 11 |
|
|
2023
Q4 | $11.2M | Buy |
72,171
+1,229
| +2% | +$179K | 1.5% | 14 |
|
|
2023
Q3 | $10.6M | Buy |
70,942
+6,080
| +9% | +$893K | 1.42% | 16 |
|
|
2023
Q2 | $8.74M | Sell |
64,862
-10,008
| -13% | -$1.47M | 1.28% | 18 |
|
|
2023
Q1 | $11.9M | Hold |
74,870
| – | – | 1.6% | 8 |
|
|
2022
Q4 | $12.1M | Sell |
74,870
-126
| -0.2% | -$19.3K | 1.62% | 9 |
|
|
2022
Q3 | $10.1M | Buy |
74,996
+280
| +0.4% | +$40.2K | 1.56% | 11 |
|
|
2022
Q2 | $11.4M | Buy |
74,716
+5,700
| +8% | +$871K | 1.73% | 10 |
|
|
2022
Q1 | $11.2M | Sell |
69,016
-4,873
| -7% | -$708K | 1.64% | 10 |
|
|
2021
Q4 | $10M | Sell |
73,889
-317
| -0.4% | -$37.4K | 1.82% | 9 |
|
|
2021
Q3 | $8M | Buy |
74,206
+5,009
| +7% | +$572K | 1.61% | 20 |
|
|
2021
Q2 | $7.79M | Buy |
69,197
+6,205
| +10% | +$699K | 1.53% | 27 |
|
|
2021
Q1 | $6.82M | Sell |
62,992
-13,177
| -17% | -$1.41M | 1.47% | 25 |
|
|
2020
Q4 | $8.16M | Sell |
76,169
-7,168
| -9% | -$689K | 2.23% | 9 |
|
|
2020
Q3 | $7.3M | Hold |
83,337
| – | – | 2.32% | 9 |
|
|
2020
Q2 | $8.18M | Hold |
83,337
| – | – | 2.42% | 5 |
|
|
2020
Q1 | $6.35M | Buy |
83,337
+1,540
| +2% | +$131K | 2.54% | 6 |
|
|
2019
Q4 | $7.24M | Buy |
81,797
+4,835
| +6% | +$401K | 1.26% | 13 |
|
|
2019
Q3 | $5.83M | Buy |
76,962
+3,987
| +5% | +$273K | 0.95% | 23 |
|
|
2019
Q2 | $5.31M | Buy |
72,975
+3,227
| +5% | +$254K | 0.82% | 30 |
|
|
2019
Q1 | $5.62M | Buy |
69,748
+959
| +1% | +$78.5K | 0.75% | 25 |
|
|
2018
Q4 | $6.34M | Buy |
68,789
+6,924
| +11% | +$609K | 0.89% | 16 |
|
|
2018
Q3 | $5.85M | Buy |
+61,865
| New | +$5.87M | 0.63% | 32 |
|
Other funds holding ABBV
Adams Asset Advisors's ABBV Position: Q2 2026 in Review
Adams Asset Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 62,912 shares worth $15.8M. The position accounts for 1.8% of the portfolio, ranked #19.
Adams Asset Advisors first reported a position in ABBV in Q3 2018 and has held it in 32 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Adams Asset Advisors held 62,912 shares of AbbVie worth $15.8M as of Q2 2026.
- Adams Asset Advisors left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 1.8% of Adams Asset Advisors's portfolio in Q2 2026, its #19 holding.
- Adams Asset Advisors first reported a position in AbbVie in Q3 2018 and has held it in 32 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Adams Asset Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.